Covered recipient · General Payments record
MELISSA LEANN FERRELL
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$2,447.23
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $618.91 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $370.67 | 10 |
| Braeburn Inc. | $135.76 | 2 |
| Lilly USA, LLC | $22.25 | 1 |
| ABBVIE INC. | $21.28 | 1 |
| Indivior Inc. | $19.62 | 1 |
| Genentech USA, Inc. | $18.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.93 | 1 |
| Novo Nordisk AS | $13.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.28 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107100624 | CMS |
| Braeburn Inc. | $116.56 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125619144 | CMS |
| Braeburn Inc. | $19.20 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125619142 | CMS |
| Genentech USA, Inc. | $18.13 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133176004 | CMS |
| GENZYME CORPORATION | $26.58 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990201 | CMS |
| GENZYME CORPORATION | $84.34 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990243 | CMS |
| GENZYME CORPORATION | $13.71 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990207 | CMS |
| GENZYME CORPORATION | $28.82 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990211 | CMS |
| GENZYME CORPORATION | $7.99 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990227 | CMS |
| GENZYME CORPORATION | $124.54 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990247 | CMS |
| GENZYME CORPORATION | $23.56 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990259 | CMS |
| GENZYME CORPORATION | $22.87 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990267 | CMS |
| GENZYME CORPORATION | $28.73 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990273 | CMS |
| GENZYME CORPORATION | $9.53 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139990285 | CMS |
| Indivior Inc. | $19.62 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144551871 | CMS |
| Lilly USA, LLC | $22.25 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135786832 | CMS |
| Novo Nordisk Inc | $13.27 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100583078 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.93 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119070384 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.